The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

The virus can be more severe in young children and in older adults, and the U.S. typically sees some 20,000 to 25,000 influenza deaths per year, though that number can reach as high as 60,000 ...

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged 75 years and above. Recent advancements in vaccine trials for older ...

The CDC says that studies of the real-world effectiveness of Arexvy during the 2023–2024 respiratory virus season showed the vaccine to be about 77 percent effective in preventing RSV-associated ...

This review by experts at the University of Aberdeen and the MRC-University of Glasgow Centre for Virus Research follows the NHS roll-out of the respiratory syncytial virus (RSV) jab, which is being ...

Both RSV vaccines include a single surface protein of the virus known as protein F. When the vaccines are made, the gene for protein F is added to cells. As the cell grows, so does the protein.

RSV is short for respiratory syncytial virus. It’s a virus that can cause respiratory infections in your lungs, nose, and throat. It’s best to test for RSV soon after your symptoms start.

Respiratory syncytial virus (RSV) infection is a common cause of lung and airway infections in infants and small children. Symptoms are similar to the common cold. Rarely, RSV may cause ...

RSV (respiratory syncytial virus) is usually more of a nuisance than a threat. But for people in high-risk groups, including older adults, it can lead to potentially life-threatening complications ...

A new study has revealed that respiratory syncytial virus (RSV), the most common cause of lower respiratory tract infections, can infect nerve cells and trigger inflammation that may contribute to ...

Updated guidance: use of palivizumab prophylaxis to prevent hospitalization from severe respiratory syncytial virus infection during the 2022-2023 RSV season. Updated November 17, 2022.